Etiology of Hemoptysis in Children and Adolescents - Multicentric Retrospective Data (2012-2021) From Chennai

D Vijayasekaran1, N C Gowrishankar2, B Sarath Balaji3

  • 1Apollo Children's Hospital and Kanchi Kamakoti Child's Trust Hospital, Chennai, Tamil Nadu.

Indian Pediatrics
|January 12, 2023
PubMed

Insights

Idiopathic pulmonary hemorrhage is the most common cause of hemoptysis in children. Severity of bleeding, from mild to severe, can help pinpoint the underlying cause, guiding necessary investigations.

Area of Science:

  • Pediatric Pulmonology
  • Pediatric Critical Care

Background:

  • Hemoptysis in children presents a diagnostic challenge due to its broad etiology.
  • Understanding the correlation between bleeding severity and cause is crucial for effective management.

Purpose of the Study:

  • To analyze the causes of hemoptysis in pediatric patients.
  • To correlate the severity of hemoptysis with its underlying etiology.

Main Methods:

  • Retrospective multicenter study of inpatient records from four tertiary pediatric hospitals in Tamil Nadu (April 2012-March 2021).
  • Included children aged 2 months to 15 years with hemoptysis, excluding those with known bleeding disorders.
  • Categorized hemoptysis into mild, moderate, and severe based on bleeding intensity.

Main Results:

  • Out of 73 children, 82.2% had mild, 12.3% had moderate, and the rest had severe hemoptysis.
  • Idiopathic pulmonary hemorrhage was the most frequent cause overall.
  • Mild hemoptysis was commonly linked to idiopathic pulmonary hemorrhage, tuberculosis, and pneumonia.
  • Congenital airway and vascular anomalies were more often associated with moderate to severe bleeding.

Conclusions:

  • The etiology of pediatric hemoptysis is diverse.
  • Classifying hemoptysis by severity (mild, moderate, severe) can provide valuable clues to the underlying cause.
  • Severity-based categorization aids in narrowing down diagnostic investigations, optimizing resource utilization.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
257
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
424
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K